Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: Concordance with ulcer swab cultures

Clinical Infectious Diseases

Volumn 42, Issue 1, 2006, Pages 57-62

  Senneville, Eric ^a   Melliez, Hugues ^a   Beltrand, Eric ^a   Legout, Laurence ^a   Valette, Michel ^a   Cazaubiel, Marie ^a   Cordonnier, Muriel ^a   Caillaux, Michèle ^a   Yazdanpanati, Yazdan ^a   Mouton, Yves ^a  

^a Dron Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BONE BIOPSY; BONE INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DIABETIC FOOT; FRACTURE; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROPATHIC JOINT DISEASE; OSTEOMYELITIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TISSUE CULTURE;

BACTERIA; BIOPSY; DIABETIC FOOT; FOOT BONES; HUMANS; MIDDLE AGED; OSTEOMYELITIS; RETROSPECTIVE STUDIES;

EID: 29244443411     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/498112     Document Type: Article

References (18)

1. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med 1997; 336: 999-1007.
2. Venkatesan P, Lawn S, Macfarlane RM, Fletcher EM, Finch RG, Jeffcoate WJ. Conservative management of osteomyelitis in the feet of diabetic patients. Diabet Med 1997; 14:487-90.
3. Senneville E, Yazdanpanah Y, Cazaubiel M, et al. Rifampin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother 2001; 48:927-30.
4. Norden CW. Lessons learned from animal models of osteomyelitis. Rev Infect Dis 1988; 10:103-10.
5. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopaedic implants. Antimicrob Agents Chemother 1993; 37:1214-8.
6. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsn PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections. JAMA 1998; 279:1537-41.
7. Powers JH. Development of drugs for antimicrobial-resistant pathogens. Curr Opin Infect Dis 2003; 16:547-51.
8. Jeffcoate WJ, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 2004; 39:5115-22.
9. Peterson LR, Lissack LM, Canter K, Fashing CE, Clabots C, Gerding DN. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med 1989; 86:801-7.
10. Pellitzer G, Strazzabosco M, Presi S, et al. Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med 2001; 18:822-7.
11. Slater RA, Lazarovitch T, Boldur I, et al. Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabet Med 2004; 21:705-9.
12. Lipsky BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Med Microbiol 1999; 26:267-76.
13. Lipsky B. Medical treatment of diabetic foot infections. Clin Infect Dis 2004; 39:5104-14.
14. Wheat JL, Allen SD, Henry M. Diabetic foot infections: bacteriologic analysis. Arch Intern Med 1986; 146:1935-40.
15. Lipsky BA, Pecoraro RE, Wheat JL. The diabetic foot: soft tissue and bone infection. Infect Dis Clin North Am 1990; 4:409-32.
16. Lipsky BA, Baker PD, Landon GC, Fernau R. Antibiotic therapy for diabetic foot infections: comparisons of two parenteral-to-oral regimens. Clin Infect Dis 1997; 24:643-8.
17. Witso E, Persen L, Loseth K, Bergh K. Adsorption and release of antibiotics from morselized cancellous bone: in vitro studies of 8 antibiotics. Acta Orthop Scand 1999; 70:298-304.
18. Mackowiak PA, Jones SR, Smith JW. Diagnostic value of sinus-tract cultures in chronic osteomyelitis. JAMA 1978; 239:2772-5.